Team:Virginia/Attributions
From 2013.igem.org
(Prototype team page) |
|||
(23 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | <!-- | + | <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"--> |
+ | <html xmlns="http://www.w3.org/1999/xhtml"> | ||
+ | <head> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> | ||
+ | <title>VGEM Welcomes You!</title> | ||
+ | <link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css"> | ||
+ | <style type="text/css"> | ||
+ | @import url("Raleway/stylesheet.css"); | ||
+ | body,td,th { | ||
+ | font-family: Raleway, sans-serif; | ||
+ | font-weight:200; | ||
+ | } | ||
+ | body { | ||
+ | background-color: #black; | ||
+ | color: white; | ||
+ | text-align: left; | ||
+ | vertical-align: baseline; | ||
+ | margin:0 auto; | ||
+ | width:95%; | ||
+ | overflow:scroll; | ||
+ | } | ||
+ | </style> | ||
+ | <style media="screen" type="text/css"> | ||
- | + | /*hide default igem banner and reformat style into blank slate*/ | |
- | + | #globalWrapper {width: 100%;} | |
- | + | #top-section {width: 100%; height:0px; border:none;} | |
- | + | #p-logo {display:none; visibility:hidden;} | |
- | </ | + | #search-controls {display:none;} |
- | < | + | #menubar a {color:#FFFFFF;} |
- | + | #menubar a:hover{text-decoration:none; color:#52749C;} | |
- | + | .left-menu {background-color:#FFFFFF; margin:0px 0px 0px 0px; padding:0;} | |
- | + | .left-menu ul {background-color:#FFFFFF; margin:0; padding:0;} | |
- | + | .right-menu ul li a {background-color:#FFFFFF;} | |
- | + | .printfooter {display:none;} | |
- | + | #footer-box {border:none;} | |
- | + | #catlinks {display:none;} | |
+ | .firstHeading {display:none;} | ||
+ | #content {width: 100%; border:none;} | ||
+ | #bodyContent {border:none;} | ||
+ | </style> | ||
+ | <style media="screen" type="text/css"> | ||
+ | @font-face { | ||
+ | font-family: 'Raleway'; | ||
+ | src: url('<link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css">') format('woff'); | ||
+ | } | ||
+ | .igemlogo { | ||
+ | position:absolute; | ||
+ | z-index:200; | ||
+ | padding:20px; | ||
+ | } | ||
+ | .slidingpics { | ||
+ | background-color: #000; | ||
+ | clear: both; | ||
+ | height: 420px; | ||
+ | margin-left: auto; | ||
+ | margin-left: auto; | ||
+ | padding:10px; | ||
+ | position:relative; | ||
+ | z-index:1; | ||
+ | } | ||
+ | .fourfocus { | ||
+ | background-color: #000; | ||
+ | color: white; | ||
+ | padding: 15px; | ||
+ | height: 380px; | ||
+ | margin-left: auto; | ||
+ | margin-right: auto; | ||
+ | padding-left:50px; | ||
+ | } | ||
- | + | .fourfocus p { | |
+ | color:#6A6A6A; | ||
+ | } | ||
+ | .fourfocus h2 { | ||
+ | color: #FFFFFF; | ||
+ | } | ||
+ | .bottom { | ||
+ | background-color: #000; | ||
+ | color: #FFFFFF; | ||
+ | padding: 15px; | ||
+ | height: 200px; | ||
+ | clear: both; | ||
+ | border-top-width: 1px; | ||
+ | border-top-style: solid; | ||
+ | border-top-color: rgba(153,153,153,0.7); | ||
+ | } | ||
+ | .footer { | ||
+ | background-color: #000000; | ||
+ | padding: 5px; | ||
+ | text-align: center; | ||
+ | display: block; | ||
+ | font-size: 12px; | ||
+ | color: #FFFFFF; | ||
+ | clear:both; | ||
+ | } | ||
+ | .footer h3 { | ||
+ | font-size: 18px; | ||
+ | text-transform: capitalize; | ||
+ | text-align: center; | ||
+ | border-bottom-width: thin; | ||
+ | border-bottom: 1px solid rgba(255,255,255,0.3); | ||
+ | color:#FFFFFF; | ||
+ | } | ||
+ | .footer a { | ||
+ | text-decoration:none; | ||
+ | color: #E94730; | ||
+ | } | ||
+ | .footer a:hover { | ||
+ | color: blue; | ||
+ | } | ||
+ | #picbox { | ||
+ | margin-left:auto; | ||
+ | margin-right:auto; | ||
+ | width:1000px; | ||
+ | padding-top:50px; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #boxes { | ||
+ | width: 1000px; | ||
+ | margin-left: auto; | ||
+ | margin-right:auto; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #fbox1 { | ||
+ | float: left; | ||
+ | width: 235px; | ||
+ | margin-right: 20px; | ||
+ | text-align:center; | ||
+ | margin-left:auto; | ||
+ | } | ||
+ | #fbox2 { | ||
+ | float: left; | ||
+ | width: 235px; | ||
+ | margin-right: 20px; | ||
+ | text-align:center; | ||
+ | } | ||
+ | #fbox3 { | ||
+ | float: left; | ||
+ | width: 235px; | ||
+ | text-align:center; | ||
+ | margin-right: 20px; | ||
+ | } | ||
+ | #fbox4 { | ||
+ | float: left; | ||
+ | width: 235px; | ||
+ | text-align:center; | ||
+ | } | ||
+ | .topbanner { | ||
+ | background-color: #000000; | ||
+ | padding: 5px; | ||
+ | height: 250px; | ||
+ | position:relative; | ||
+ | z-index:100; | ||
+ | } | ||
+ | #logo { | ||
+ | height: 110px; | ||
+ | margin: 30px auto 0px auto; | ||
+ | } | ||
+ | #VGEM, #logo p { | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | } | ||
+ | #VGEM { | ||
+ | text-align: center; | ||
+ | text-transform: uppercase; | ||
+ | color:#FFFFFF; | ||
+ | } | ||
+ | #VGEM span { | ||
+ | color: #E94730; | ||
+ | } | ||
+ | #logo p#VGEM a { | ||
+ | font-size: 60px; | ||
+ | color: #FFF; | ||
+ | font-weight:400; | ||
+ | } | ||
+ | #logo p { | ||
+ | text-align: center; | ||
+ | text-transform: uppercase; | ||
+ | font-size: 25px; | ||
+ | font-family: 'Raleway', sans-serif; | ||
+ | color: #595959; | ||
+ | } | ||
+ | #logo p a { | ||
+ | color:#595959; | ||
+ | } | ||
+ | #logo a { | ||
+ | border: none; | ||
+ | background: none; | ||
+ | text-decoration: none; | ||
+ | color: #1F1F1F; | ||
+ | } | ||
+ | #menu11 ul { | ||
+ | text-transform: uppercase; | ||
+ | font-size: 18px; | ||
+ | line-height: 1.2em; | ||
+ | clear: both; | ||
+ | margin-left: auto; | ||
+ | margin-right:auto; | ||
+ | height:70px; | ||
+ | width:900px; | ||
+ | } | ||
+ | #menu11 ul li{ | ||
+ | display:block; | ||
+ | text-decoration:none; | ||
+ | padding:0px 0px 0px 10px; | ||
+ | width:150px; | ||
+ | height:55px; | ||
+ | border-left:6px dotted #fff; | ||
+ | float:left; | ||
+ | } | ||
+ | #menu11 ul li span{ | ||
+ | display:block; | ||
+ | } | ||
+ | #menu11 ul li span.title{ | ||
+ | color:#fff; | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | #menu11 ul li:hover{ | ||
+ | border-left:10px dotted #E94730; | ||
+ | } | ||
+ | #menu11 ul li:hover span.title{ | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | #menu11 ul li span.text{ | ||
+ | color: #325281; | ||
+ | font-size: 14px; | ||
+ | letter-spacing: 0px; | ||
+ | visibility: hidden; | ||
+ | line-height: 0px; | ||
+ | padding-top: 8px; | ||
+ | list-style-type: square; | ||
+ | background-color: #000000; | ||
+ | padding-bottom:2px; | ||
+ | padding-left:2px; | ||
+ | border-radius:10px; | ||
+ | } | ||
+ | #menu11 ul li:hover span.text{ | ||
+ | visibility:visible; | ||
+ | } | ||
+ | #menu11 ul li:hover span.text a{ | ||
+ | text-decoration: none; | ||
+ | color: #66CCFF; | ||
+ | } | ||
+ | .body { | ||
+ | clear:both; | ||
+ | position:relative; | ||
+ | z-index:1; | ||
+ | background-color: #000000; | ||
+ | padding:10px; | ||
+ | color:#FFFFFF; | ||
+ | } | ||
+ | #grouppic { | ||
+ | margin-left: auto; | ||
+ | margin-right: auto; | ||
+ | width:900px; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
+ | #groupbio { | ||
+ | width: 950px; | ||
+ | margin-right: auto; | ||
+ | margin-left:auto; | ||
+ | line-height: 1.7 em; | ||
+ | font-size:17px; | ||
+ | border: 3px solid rgba(255,255,255,0.3); | ||
+ | padding: 10px; | ||
+ | } | ||
+ | #bethke { | ||
+ | width:90%; | ||
+ | padding-left:10%; | ||
+ | height: 300px; | ||
+ | border-bottom: 1px solid rgba(255,255,255,0.3); | ||
+ | clear:both; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #bethke img { | ||
+ | float: left; | ||
+ | padding:20px 50px 0px 50px; | ||
+ | |||
+ | } | ||
+ | #bethke h2 { | ||
+ | color:#FFFFFF; | ||
+ | } | ||
+ | #brown { | ||
+ | width: 90%; | ||
+ | padding-left:10%; | ||
+ | height:300px; | ||
+ | border-bottom: 1px solid rgba(255,255,255,0.3); | ||
+ | clear:both; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #brown img { | ||
+ | float:left; | ||
+ | padding:20px 50px 0px 50px; | ||
+ | } | ||
+ | #pictext{ | ||
+ | float: left; | ||
+ | width: 450px; | ||
+ | } | ||
+ | #pictext h2 { | ||
+ | color:#FFFFFF; | ||
+ | } | ||
+ | #pictext p { | ||
+ | font-size:14px; | ||
+ | } | ||
+ | #moshasha { | ||
+ | width:90%; | ||
+ | padding-left:10%; | ||
+ | height: 300px; | ||
+ | clear:both; | ||
+ | } | ||
+ | #moshasha img { | ||
+ | float: left; | ||
+ | padding:20px 50px 0px 50px; | ||
+ | </style> | ||
- | + | </head> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | <body> | ||
+ | <div class="igemlogo"> | ||
+ | <a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/igem.org/1/17/IGEM_basic_Logo_white_stylized.png" width="70"> </a> | ||
+ | </div> | ||
+ | <div class="topbanner"> | ||
+ | <div id="logo"> | ||
+ | <p id="VGEM"><a href="https://2013.igem.org/Team:Virginia"><span>V</span>GEM</a></p> | ||
+ | <p><a href="http://www.virginia.edu/"> University of Virginia</a></p> | ||
+ | </div> | ||
+ | <div id="menu11"> | ||
+ | <ul> | ||
+ | <li> | ||
+ | <span class="title">Home</span> | ||
+ | <span class="text"><a href="https://2013.igem.org/Team:Virginia">The start</a></span> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span class="title">Project</span> | ||
+ | <span class="text"> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Project_Overview">Overview</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Background">Background</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Parts">Parts</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Results">Results</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Modeling">Modeling</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Software">Software</a></p> | ||
- | + | <p><a href="https://2013.igem.org/Team:Virginia/Chassis_Improvements">Chassis Improvements</a></p></span> | |
+ | </li> | ||
+ | <li> | ||
+ | <span class="title">Notebook</span> | ||
+ | <span class="text"> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Notebook_Overview">Overview</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Notebook">Notebook</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Protocols">Protocols</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Gallery">Gallery</a></p></span> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span class="title">Human Practices</span> | ||
+ | <span class="text"> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Human_Practices_Overview">Overview</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Safety Considerations">Safety Considerations</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/High_School_Education_Series">High School Education Series</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Documentary">Documentary</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Media_Coverage">Media Coverage</a></p></span> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span class="title">Team</span> | ||
+ | <span class="text"> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Team_Overview">Overview</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Bios">Bios</a></p> | ||
+ | <p><a href="https://igem.org/Team.cgi?year=2013&team_name=Virginia">Profile</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Sponsors">Sponsors</a></p> | ||
+ | <p><a href="https://2013.igem.org/Team:Virginia/Attributions">Attributions</a></p></span></li></ul></div></div> | ||
+ | <div class="body"> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/thumb/b/b8/VgemKoz.jpg/432px-VgemKoz.jpg" width="175"> | ||
+ | <div id="pictext"><h2>Keith Kozminski, PhD - Team Advisor</h2> | ||
+ | <p>Associate Professor of Biology, University of Virginia</p> | ||
+ | <p>As advisor of all things iGEM-related, Prof. Kozminski proved an invaluable source of information and aid at all hours of the day and night. We are eternally grateful for his support, and can only hope that a trip to Canada and a copious supply of banana bread demonstrate our appreciation.</p></div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Inchan Kwon, PhD - Team Advisor</h2> | ||
+ | <p>Assistant Professor of Chemical Engineering, University of Virginia</p> | ||
+ | <p>As a source of consistent support through regular meetings and project discussions, we greatly appreciate Prof. Kwon’s work as an advisor.</p></div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/a/ab/VgemKwon.jpg" width="150"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/a/ad/Papin.jpg" width="150"> | ||
+ | <div id="pictext"><h2>Jason Papin, PhD - Team Advisor</h2> | ||
+ | <p>Associate Professor of Biomedical Engineering, University of Virginia</p> | ||
+ | <p>As a source of invaluable computer modeling knowledge, we are truly thankful for Prof. Papin as an advisor. We appreciate his direction in both project development and analysis.</p></div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Matthew Giacalone, PhD - Minicell Formation</h2> | ||
+ | <p>Vice President of Corporate Development and Research at Vaxiion Therapeutics</p> | ||
+ | <p>Dr. Giacalone guided our minicell formation and characterization teams with recommendations regarding FtsZ upregulation and IPTG induction.</p> | ||
+ | </div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/c/c9/Giacalone.png" width="250"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/4/45/Kriss.jpg" width="150"> | ||
+ | <div id="pictext"><h2>Alison Criss, PhD - BioSafety and Protocol Development</h2> | ||
+ | <p>Assistant Professor of Microbiology, Immunology, and Cancer Biology, University of Virginia</p> | ||
+ | <p>Providing truly invaluable support and encouragement, Dr. Criss guided our project’s development as we first investigated minicells. As our research progressed, her advice regarding protocol development and her insight into bioethical considerations proved essential, and we are truly grateful for her support.</p></div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Vinod Jyothikumar, PhD - Imaging and Modeling</h2> | ||
+ | <p>Keck Center for Cellular Imaging (KCCI)</p> | ||
+ | <p>With incredible knowledge regarding imaging techniques, Mr. Jyothikumar provided incredible insight regarding minicell visualization and quantification, as well as PSR quantification. We greatly appreciate his support.</p></div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/8/85/Vinod.png" width="150"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/7/7d/Michael_Wormington.png" width="220"> | ||
+ | <div id="pictext"><h2>Michael Wormington, PhD - Minicells as a Biological Chassis</h2> | ||
+ | <p>Associate Professor and Associate Chair of Biology, University of Virginia</p> | ||
+ | <p>Prof. Wormington provided key feedback during the early stages of our project’s development. As he first suggested that we study minicell’s potential as a chassis rather than as vaccine mechanism, we are eternally grateful for his direction.</div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>David Kittlesen, PhD - Immunology and Minicells</h2> | ||
+ | <p>Lecturer of Biology and Director of Biology Summer Session, University of Virginia</p> | ||
+ | <p>We greatly appreciate Prof. Kittlesen’s insight into the immune system, particularly with regard to potential immune response to minicells.</p> | ||
+ | </div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/b/b3/Kittle.png" width="150"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/d/da/Kaych.png" width="150"> | ||
+ | <div id="pictext"><h2>Kay Christopher - Laboratory Manager</h2> | ||
+ | <p>Upper Level Labs Preparator, University of Virginia</p> | ||
+ | <p>Mrs. Christopher graciously helped us secure our labspace, providing us with laboratory materials and checking that our equipment complied with all appropriate biosafety requirements.</p> | ||
+ | </div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Daniel Engel, PhD - Laboratory Support</h2> | ||
+ | <p>Professor of Microbiology, Immunology, and Cancer Biology, University of Virginia</p> | ||
+ | <p>Dr. Engel generously provided additional BSL-2 lab space, equipment, and resources necessary for our project.</p> | ||
+ | </div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/2/22/Engel.png" width="120"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/7/73/Linda_Columbus_03HR_JL.jpg" width="250"> | ||
+ | <div id="pictext"><h2>Linda Columbus, PhD - Laboratory Support</h2> | ||
+ | <p>Associate Professor of Chemistry, Molecular Physiology, and Biological Physics, University of Virginia</p> | ||
+ | <p>Dr. Columbus generously provided additional lab space, equipment, and resources necessary for our project.</p> | ||
+ | </div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Loren Erickson, PhD - Laboratory Support</h2> | ||
+ | <p>Associate Professor, Microbiology, Immunology, and Cancer Biology, University of Virginia</p> | ||
+ | <p>Dr. Erickson generously provided secondary antibodies required by our applications team.</p> | ||
+ | </div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/5/57/Loren.png" width="150"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/c/c5/Virginia_Miller.jpg" width="150"> | ||
+ | <div id="pictext"><h2>Virginia Miller, PhD, and Kimberly Walker, PhD - Ail Plasmid</h2> | ||
+ | <p>Department of Genetics, School of Medicine, UNC-Chapel Hill</p> | ||
+ | <p>A renowned expert on the Yersinia ail gene, Dr. Miller works as a professor in the Department of Genetics at the University of North Carolina, Chapel Hill. Dr. Walker, a research professor in the Miller lab, kindly donated the ail plasmid used by our applications team, while also providing invaluable expertise regarding various protocols.</p> | ||
+ | </div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Willie Vann, PhD - pSR23 Plasmid</h2> | ||
+ | <p>Food and Drug Administration</p> | ||
+ | <p>Dr. Vann kindly donated the pSR23 plasmid used by our applications team, while also providing invaluable expertise regarding various protocols.</p></div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/8/89/Willie_Vann_%28FDA%29.png"></div> | ||
+ | <div id="bethke"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/9/98/VgemRenaissance.jpg" width="175"> | ||
+ | <div id="pictext"><h2>Becky Wilbur, PhD, and Anna Minutella</h2> | ||
+ | <p>Renaissance School – High School Collaboration</p> | ||
+ | <p>A local high school in downtown Charlottesville, Renaissance worked with our team to develop an educational workshop series. We appreciate their enthusiasm regarding our programming, as they have even expanded their curriculum to include a DNA Science Course.</p></div></div> | ||
+ | <div id="brown"> | ||
+ | <div id="pictext"><h2>Dr. Michael Timko - Bioethical Considerations and Laboratory Support</h2> | ||
+ | <p>Director of the Human Biology Program and Professor of Biology, University of Virginia</p> | ||
+ | <p>Dr. Michael Timko graciously agreed to an interview regarding the bioethical considerations of synthetic biology. In addition, we are truly grateful for his laboratory support, sharing various resources with our team.</p></div> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/c/c5/Michael_Timko.png" width="150"></div> | ||
+ | <div id="moshasha"> | ||
+ | <img src= "https://static.igem.org/mediawiki/2013/4/4d/John_Arras.png"> | ||
+ | <div id="pictext"><h2>Dr. John Arras - Bioethical Considerations</h2> | ||
+ | <p>U.S. Presidential Commission on Bioethics</p> | ||
+ | <p>Dr. John Arras graciously agreed to an interview regarding the bioethical considerations of synthetic biology, providing invaluable insight regarding oversight mechanisms, biosafety concerns, open source research, and our minicell project.</p> | ||
+ | </div></div> | ||
+ | </div> | ||
+ | <div class="footer"> | ||
+ | <h3> </h3> | ||
+ | <h3>Contact</h3> | ||
+ | <p>Questions? Comments? Email us at <a href="virginia.igem@gmail.com">virginia.igem@gmail.com</a></p> | ||
+ | </div> | ||
+ | |||
+ | <p> </p> | ||
+ | </body> | ||
+ | </html> |
Latest revision as of 02:54, 7 November 2013
Keith Kozminski, PhD - Team Advisor
Associate Professor of Biology, University of Virginia
As advisor of all things iGEM-related, Prof. Kozminski proved an invaluable source of information and aid at all hours of the day and night. We are eternally grateful for his support, and can only hope that a trip to Canada and a copious supply of banana bread demonstrate our appreciation.
Inchan Kwon, PhD - Team Advisor
Assistant Professor of Chemical Engineering, University of Virginia
As a source of consistent support through regular meetings and project discussions, we greatly appreciate Prof. Kwon’s work as an advisor.
Jason Papin, PhD - Team Advisor
Associate Professor of Biomedical Engineering, University of Virginia
As a source of invaluable computer modeling knowledge, we are truly thankful for Prof. Papin as an advisor. We appreciate his direction in both project development and analysis.
Matthew Giacalone, PhD - Minicell Formation
Vice President of Corporate Development and Research at Vaxiion Therapeutics
Dr. Giacalone guided our minicell formation and characterization teams with recommendations regarding FtsZ upregulation and IPTG induction.
Alison Criss, PhD - BioSafety and Protocol Development
Assistant Professor of Microbiology, Immunology, and Cancer Biology, University of Virginia
Providing truly invaluable support and encouragement, Dr. Criss guided our project’s development as we first investigated minicells. As our research progressed, her advice regarding protocol development and her insight into bioethical considerations proved essential, and we are truly grateful for her support.
Vinod Jyothikumar, PhD - Imaging and Modeling
Keck Center for Cellular Imaging (KCCI)
With incredible knowledge regarding imaging techniques, Mr. Jyothikumar provided incredible insight regarding minicell visualization and quantification, as well as PSR quantification. We greatly appreciate his support.
Michael Wormington, PhD - Minicells as a Biological Chassis
Associate Professor and Associate Chair of Biology, University of Virginia
Prof. Wormington provided key feedback during the early stages of our project’s development. As he first suggested that we study minicell’s potential as a chassis rather than as vaccine mechanism, we are eternally grateful for his direction.
David Kittlesen, PhD - Immunology and Minicells
Lecturer of Biology and Director of Biology Summer Session, University of Virginia
We greatly appreciate Prof. Kittlesen’s insight into the immune system, particularly with regard to potential immune response to minicells.
Kay Christopher - Laboratory Manager
Upper Level Labs Preparator, University of Virginia
Mrs. Christopher graciously helped us secure our labspace, providing us with laboratory materials and checking that our equipment complied with all appropriate biosafety requirements.
Daniel Engel, PhD - Laboratory Support
Professor of Microbiology, Immunology, and Cancer Biology, University of Virginia
Dr. Engel generously provided additional BSL-2 lab space, equipment, and resources necessary for our project.
Linda Columbus, PhD - Laboratory Support
Associate Professor of Chemistry, Molecular Physiology, and Biological Physics, University of Virginia
Dr. Columbus generously provided additional lab space, equipment, and resources necessary for our project.
Loren Erickson, PhD - Laboratory Support
Associate Professor, Microbiology, Immunology, and Cancer Biology, University of Virginia
Dr. Erickson generously provided secondary antibodies required by our applications team.
Virginia Miller, PhD, and Kimberly Walker, PhD - Ail Plasmid
Department of Genetics, School of Medicine, UNC-Chapel Hill
A renowned expert on the Yersinia ail gene, Dr. Miller works as a professor in the Department of Genetics at the University of North Carolina, Chapel Hill. Dr. Walker, a research professor in the Miller lab, kindly donated the ail plasmid used by our applications team, while also providing invaluable expertise regarding various protocols.
Willie Vann, PhD - pSR23 Plasmid
Food and Drug Administration
Dr. Vann kindly donated the pSR23 plasmid used by our applications team, while also providing invaluable expertise regarding various protocols.
Becky Wilbur, PhD, and Anna Minutella
Renaissance School – High School Collaboration
A local high school in downtown Charlottesville, Renaissance worked with our team to develop an educational workshop series. We appreciate their enthusiasm regarding our programming, as they have even expanded their curriculum to include a DNA Science Course.
Dr. Michael Timko - Bioethical Considerations and Laboratory Support
Director of the Human Biology Program and Professor of Biology, University of Virginia
Dr. Michael Timko graciously agreed to an interview regarding the bioethical considerations of synthetic biology. In addition, we are truly grateful for his laboratory support, sharing various resources with our team.
Dr. John Arras - Bioethical Considerations
U.S. Presidential Commission on Bioethics
Dr. John Arras graciously agreed to an interview regarding the bioethical considerations of synthetic biology, providing invaluable insight regarding oversight mechanisms, biosafety concerns, open source research, and our minicell project.